Rachael Nokes

Officer, scPharmaceuticals (United States).

Companies

scPharmaceuticals (United States)Chief financial officer Jan 3, 2024 to now¹
scPharmaceuticals (United States)Officer Mar 6, 2019 to Jan 23, 2023²

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Oct 7, 2025Returned to company 125,675 shares of scPharmaceuticals (United States)³
Oct 7, 2025U 30,386 shares of scPharmaceuticals (United States)³
Feb 11, 2025Granted 88,445 shares of scPharmaceuticals (United States)⁴
Jan 3, 2025Shares withheld for tax 5,235 shares at $3.56 of scPharmaceuticals (United States)⁵
Aug 6, 2024Exercised options 10,445 shares at $1.66 of scPharmaceuticals (United States)⁶
Aug 6, 2024Exercised options 10,445 shares of scPharmaceuticals (United States)⁷
Jan 18, 2024Granted 41,840 shares of scPharmaceuticals (United States)⁸
Jan 2, 2024Shares withheld for tax 1,027 shares at $6.39 of scPharmaceuticals (United States)⁹
Jan 19, 2023Granted 11,700 shares at $6.14 of scPharmaceuticals (United States)¹⁰
Feb 25, 2021Shares withheld for tax 1,976 shares at $7.27 of scPharmaceuticals (United States)¹⁰
Feb 25, 2020Shares withheld for tax 1,981 shares at $10.09 of scPharmaceuticals (United States)¹⁰

The numbers on this page point here. Each one links to the record it came from.